RSCRX
Price
$25.69
Change
+$0.20 (+0.78%)
Updated
Dec 24 closing price
VSCIX
Price
$116.87
Change
+$0.97 (+0.84%)
Updated
Dec 24 closing price
Ad is loading...

RSCRX vs VSCIX

Header iconRSCRX vs VSCIX Comparison
Open Charts RSCRX vs VSCIXBanner chart's image
Russell Inv US Small Cap Equity R6
Price$25.69
Change+$0.20 (+0.78%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$116.87
Change+$0.97 (+0.84%)
VolumeN/A
CapitalizationN/A
RSCRX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RSCRX vs. VSCIX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSCRX is a Buy and VSCIX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 167B vs. RSCRX (729M). VSCIX pays higher dividends than RSCRX: VSCIX (1.43) vs RSCRX (0.61). RSCRX was incepted earlier than VSCIX: RSCRX (9 years) vs VSCIX (27 years). RSCRX is a more actively managed with annual turnover of: 80.00 vs. VSCIX (12.00). RSCRX has a lower initial minimum investment than VSCIX: RSCRX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 14.59 vs. RSCRX (-1.16). VSCIX return over 5 years is better than : 49.25 vs. RSCRX (-6.32).
RSCRXVSCIXRSCRX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years27 years-
Gain YTD-1.20014.750-8%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets729M167B0%
Annual Yield % from dividends0.611.4343%
Returns for 1 year-1.1614.59-8%
Returns for 3 years-11.4310.04-114%
Returns for 5 years-6.3249.25-13%
Returns for 10 yearsN/A115.70-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USEG1.530.04
+2.68%
US Energy Corp
ON67.901.27
+1.91%
ON Semiconductor Corp
AMTX2.630.04
+1.54%
Aemetis
ARDX4.640.06
+1.31%
Ardelyx
APLS33.320.11
+0.33%
Apellis Pharmaceuticals